AIGH Capital Management »

Lipocine shares owned by AIGH Capital Management

Quarter-by-quarter ownership of Lipocine (LPCN) shares owned by AIGH Capital Management from 13F filings

Historical chart of AIGH Capital Management investment in Lipocine

Tip: Access up to 7 years of quarterly data

All positions including Lipocine held by AIGH Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lipocine by AIGH Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.6M 200k 7.99

More positions owned by AIGH Capital Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Sandisk Corp (SNDK)
Zoom Communications Cl A Call Option (ZM)
Select Sector Spdr Tr State Street Tec Put Option (XLK)
Tigo Energy (TYGO)
Silicon Motion Technology Sponsored Adr (SIMO)
Zebra Technologies Corporati Cl A (ZBRA)
Nlight (LASR)
Vanda Pharmaceuticals (VNDA)
Personalis Ord (PSNL)
Generac Holdings (GNRC)
Kyverna Therapeutics (KYTX)
Castle Biosciences (CSTL)
Digital Turbine Com New (APPS)
Regal-beloit Corporation (RRX)

View all positions for AIGH Capital Management

Top funds holding Lipocine

Ikarian Capital
Squadron Capital Management
Diadema Partners
Vanguard Group
Vanguard Capital Management
AIGH Capital Management
Stempoint Capital
Boothbay Fund Management
Seven Fleet Capital Management
Birchview Capital
BlackRock
Mink Brook Asset Management
Geode Capital Management
Renaissance Technologies
Two Sigma Investments

View all funds holding Lipocine